The identification of specific expression profiles of miRNAs specifically characterizing neuroendocrine tumor cells in MEN1 patients is an important step for the future development of target RNA antagomirs-based strategies to control the MEN1 tumorigenesis. This evidence concerns the gene MEN1 and neuroendocrine neoplasm.